(Q44567701)

4 December 2017

DNA-based immunization against hepatitis B virus (English)

1 reference

4 December 2017

0 references

1 reference

Davis HL

1

1 reference

PubMed ID

9406346

4 December 2017

Brazolot Millan CL

series ordinal

2

1 reference

4 December 2017

1 January 1997

1 reference

Seminars in Immunopathology

4 December 2017

1 reference

4 December 2017

19

1 reference

4 December 2017

2

1 reference

4 December 2017

195-209

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00870268

4 December 2017

0 references

cites work

Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus

1 reference

12 December 2020

DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines

1 reference

12 December 2020

Genetic immunization is a simple method for eliciting an immune response

1 reference

12 December 2020

Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin

1 reference

12 December 2020

Hepatitis B virus contains pre-S gene-encoded domains

1 reference

12 December 2020

Induction of anti-hepatitis B surface antigen (HBsAg) antibodies in HBsAg producing transgenic mice: a possible way of circumventing "nonresponse" to HBsAg.

1 reference

12 December 2020

DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein

1 reference

12 December 2020

Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle

1 reference

12 December 2020

The immune response to hepatitis B vaccine in humans: inheritance patterns in families

1 reference

12 December 2020

DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state

1 reference

12 December 2020

Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness

1 reference

12 December 2020

Neonatal Tolerance Revisited: Turning on Newborn T Cells with Dendritic Cells

1 reference

12 December 2020

Direct gene transfer into mouse muscle in vivo

1 reference

12 December 2020

T- and B-cell recognition of hepatitis B viral antigens

1 reference

12 December 2020

Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA.

1 reference

12 December 2020

Hepatitis B virus antigens made in microbial cells immunise against viral infection

1 reference

12 December 2020

Update on hepatitis B prevention

1 reference

12 December 2020

The molecular biology of the hepatitis B viruses

1 reference

12 December 2020

Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen

1 reference

12 December 2020

Synthesis and assembly of hepatitis B virus surface antigen particles in yeast

1 reference

12 December 2020

Protection against hepatitis B virus infection by immunization with hepatitis B core antigen

1 reference

12 December 2020

Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus

1 reference

12 December 2020

DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost.

1 reference

12 December 2020

Live recombinant vaccinia virus protects chimpanzees against hepatitis B.

1 reference

12 December 2020

Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice

1 reference

12 December 2020

DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans

1 reference

12 December 2020

DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody

1 reference

12 December 2020

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

1 reference

12 December 2020

Hepatitis B subunit vaccine: a preliminary report of safety and efficacy tests in chimpanzees.

1 reference

12 December 2020

Development and chimpanzee testing of a vaccine against human hepatitis B.

1 reference

12 December 2020

A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees

1 reference

12 December 2020

Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo

1 reference

12 December 2020

Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice

1 reference

12 December 2020

Immunisation against hepatitis B in man

1 reference

12 December 2020

Hepatitis B Vaccine Passes First Major Test

1 reference

12 December 2020

Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing

1 reference

12 December 2020

Antibody response to pre-S2 and hepatitis B virus induced liver damage

1 reference

12 December 2020

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00870268

1 reference

4 December 2017

1 reference

PubMed ID

9406346